Last update 21 Nov 2024

OK-101

Overview

Basic Info

Drug Type
Recombinant polypeptide
Synonyms
+ [1]
Mechanism
Chemerin receptors agonists
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeuralgiaPhase 2
US
15 Oct 2024
Dry Eye SyndromesPhase 2
US
28 Apr 2023
Corneal DiseasesIND Approval
US
09 Feb 2024
Conjunctivitis, AllergicPreclinical
US
15 Jul 2022
UveitisPreclinical
US
15 Jul 2022
COVID-19Preclinical
GB
19 Jan 2021
Ocular inflammationPreclinical
GB
23 Jan 2019
XerophthalmiaPreclinical
GB
23 Jan 2019
Cytokine Release SyndromePreclinical
US
-
Cytokine Release SyndromePreclinical
GB
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
240
OK-101 ophthalmic solution
jdikqnvveo(ikaeofhkev) = jpostioegd ffijazlbcp (rayrsbcjel )
Met
Positive
10 Jul 2024
Placebo
jdikqnvveo(ikaeofhkev) = ihmjxnjnyb ffijazlbcp (rayrsbcjel )
Met
Phase 2
240
OK-101 0.05%
-
Positive
22 Mar 2024
OK-101 0.1%
Phase 2
240
(dcqtmaayky): P-Value = 0.034
Positive
08 Jan 2024
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free